Forum for Innovative Regenerative Medicine (FIRM) organized the session to exchange views with the media on January 20, 2016.
FIRM presented and explained its progress on its international exchange activities and its activity reports of Regenerative
Medicine Industrialization Task Force (RMIT), the release of the FIRM Standards and Guidelines, its own views on two products
approved under the new laws, and exchanged views with the media. FIRM will continue to make every effort to disseminate
necessary information to the media.